<DOC>
	<DOC>NCT02510560</DOC>
	<brief_summary>The study will evaluate the effect of NTRA-2112 on intestinal malabsorption in preterm infants.</brief_summary>
	<brief_title>Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants</brief_title>
	<detailed_description>The study will assess the efficacy and safety of NTRA-2112 on intestinal malabsorption in preterm infants as compared to placebo</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Malabsorption Syndromes</mesh_term>
	<criteria>Inclusion Criteria 1. Male or female preterm infant 26 and up to 32 weeks gestation. Gestational age matching (±2 weeks) between maternal dates and/or early antenatal ultrasound 2. Birth weight ≥ 500g 3. Singleton or twin birth Exclusion Criteria 1. Complete enteral feeding</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>5 Days</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>